Oversea-Chinese Banking Corp (OCBC)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Buy
12,589
+9,592
+320% +$2.23M 0.08% 159
2025
Q4
$620K Sell
2,997
-7,992
-73% -$1.58M 0.02% 245
2025
Q3
$2.04M Sell
10,989
-2,539
-19% -$435K 0.05% 168
2025
Q2
$2.06M Sell
13,528
-7,489
-36% -$1.15M 0.06% 163
2025
Q1
$3.45M Buy
21,017
+16,132
+330% +$2.52M 0.1% 136
2024
Q4
$706K Sell
4,885
-8,180
-63% -$1.27M 0.02% 249
2024
Q3
$2.11M Buy
13,065
+10,950
+518% +$1.74M 0.06% 171
2024
Q2
$311K Sell
2,115
-1,844
-47% -$274K 0.01% 319
2024
Q1
$626K Buy
+3,959
New +$630K 0.02% 271
2023
Q4
Sell
-7,934
Closed -$1.24M 362
2023
Q3
$1.24M Buy
+7,934
New +$1.31M 0.06% 180

Other funds holding JNJ

Oversea-Chinese Banking Corp (OCBC)'s JNJ Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its Johnson & Johnson (JNJ) stake by 320% in Q1 2026, buying an estimated $2.23M and bringing the position to 12,589 shares worth $3.08M. The position accounts for 0.08% of the portfolio, ranked #159.

Oversea-Chinese Banking Corp (OCBC) first reported a position in JNJ in Q3 2023 and has held it in 10 quarters since. The position peaked at $3.45M in Q1 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 12,589 shares of Johnson & Johnson worth $3.08M as of Q1 2026.
  • Oversea-Chinese Banking Corp (OCBC) bought 9,592 Johnson & Johnson shares in Q1 2026, an estimated $2.23M.
  • Johnson & Johnson made up 0.08% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #159 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Johnson & Johnson in Q3 2023 and has held it in 10 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s Johnson & Johnson position peaked at $3.45M in Q1 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.